Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.

Aslam, Waqas; Lamb, Carla R; Ali, Nadia

Aslam, Waqas; Lamb, Carla R; Ali, Nadia.

Affiliation

Aslam W; Pulmonary and Critical Care Medicine, Interventional Pulmonology, University of California San Francisco, Fresno, California, USA drwaqasaslam@yahoo.com.
Lamb CR; Pulmonary and Critical Care Medicine, Interventional Pulmonology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
Ali N; Internal Medicine & Geriatrics, Hebrew Senior Life, Harvard Medical School Affiliate, Roslindale, Massachusetts, USA.

BMJ Case Rep ; 14(3)2021 Mar 24.

Article in En | MEDLINE | ID: mdl-33762277

Subject(s)

COVID-19 Drug Treatment; Dexamethasone/adverse effects; Hydroxychloroquine/adverse effects; Torsades de Pointes/chemically induced; Aged; Anti-Infective Agents/adverse effects; Anti-Infective Agents/therapeutic use; Citalopram/adverse effects; Citalopram/therapeutic use; Dexamethasone/therapeutic use; Donepezil/adverse effects; Donepezil/therapeutic use; Drug Therapy, Combination; Electrocardiography/methods; Female; Heart Diseases/chemically induced; Heart Diseases/prevention & control; Humans; Hydroxychloroquine/therapeutic use; Long QT Syndrome/chemically induced; SARS-CoV-2

Key words

arrhythmias; pneumonia (infectious disease); unwanted effects / adverse reactions

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Dexamethasone / Torsades de Pointes / COVID-19 Drug Treatment / Hydroxychloroquine Limits: Aged / Female / Humans Language: En Journal: BMJ Case Rep Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google